Table 6. Clinical data and follow up in the leprosy patients treated.
Supervised monthly MDT-dose | 1st | 2nd | 3rd | 4th | 5 th | 6 th | 7 th | 8 th | 9 th | 10th | 11th | 12th |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Number of followed-up patients | 29 | 25 | 21 | 13 | 12 | 11 | 9 | 6 | 4 | 2 | 2 | 2 |
Signs & Symptoms | ||||||||||||
Improvement of neurological symptoms (cramps, numbness and/or tingling) | P14 | P26 P13 |
P28 P25 |
P06 P20 |
P25 | |||||||
Improvement of neural pain on palpation | P14 | P13 | P28 | |||||||||
Improvement of esthesiometry | P26 | P25 | P18 | |||||||||
Improvement of WHO impairment grading | P25 | P06 P20 |
||||||||||
Appearing of ichthyosis in islets in the lower limbs | P26 P13 |
P06 P26 P20 |
P32 | P32 | P25 | |||||||
Improvement of skin sensitivity | P27 | |||||||||||
Conjunctival eye irritability/dryness | P32 | P06 | P32 | |||||||||
Skin lesions became more evident | P09 | |||||||||||
Skin lesions became less evident | P31 | P31 | P11 | |||||||||
Appearing of numbness and cramps | P27 | |||||||||||
Improvement of cutaneous reflex by endogenous histamine test | P31 | |||||||||||
Neuritis | P11 | |||||||||||
Pain on neural palpation | P18 | |||||||||||
Total patients with manifest symptoms/signs | 0 | 1 | 6 | 2 | 2 | 0 | 5 | 3 | 1 | 1 | 1 |
P: patient.